Where does Inserm-institut DE LA Recherche MÉDICALE rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inserm-institut DE LA Recherche MÉDICALE ranks #35,891 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Inserm-institut DE LA Recherche MÉDICALE hold?

Inserm-institut DE LA Recherche MÉDICALE holds 7 US utility patents granted between 2018 and 2019, spanning 5 technology areas.

What is Inserm-institut DE LA Recherche MÉDICALE's Innovation Score?

Inserm-institut DE LA Recherche MÉDICALE has an Innovation Score of 25.3 out of 100 (17th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Inserm-institut DE LA Recherche MÉDICALE focus on?

Inserm-institut DE LA Recherche MÉDICALE's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 6 patents, ranking #583 of 1,943 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Inserm-institut DE LA Recherche MÉDICALE's patent grant rate increasing or decreasing?

Inserm-institut DE LA Recherche MÉDICALE's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Inserm-institut DE LA Recherche MÉDICALE's patents?

Inserm-institut DE LA Recherche MÉDICALE's patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Inserm-institut DE LA Recherche MÉDICALE patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Inserm-institut DE LA Recherche MÉDICALE

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2018–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inserm-institut ranks #35,891 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#35,891
of 49,997 US assignees by volume: 17th percentile
by Innovation Score (25.3/100): 17.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R35891 · Foreign Corporation #35,891 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #35,891/49,997
PHOTO-FINISH Inoex Innovationen…
CPC-NARROW A61N · 5 areas
INNOV-THIN 25.3/100
CLAIMS-RICH 17.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Inoex GMBH Innovationen UND AUSRÜSTUNGEN FÜR DIE Extrusionstechnik (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Inserm-institut’s 25.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (28%) Velocity 0.0 pts (0%) Breadth 7.9 pts (31%) Claim depth 10.2 pts (40%)

Qualcomm Incorporated · highest

85
Inserm-institut DE… · this assignee

25
3D Lighting… · lowest

7

What this shows Inserm-institut's Innovation Score is 25.3/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Inserm-institut?

Each dot is one of Inserm-institut’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Inserm-institut’s own 17.0 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Inserm-institut vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Inserm-institut's grants concentrate

Inserm-institut DE LA Recherche MÉDICALE is a focused PatentsView assignee: 5 CPC subclasses with 85.7% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2018 (4 grants) versus a trough of 3 in 2019. By volume, Inserm-institut sits between Inoex GMBH Innovationen UND AUSRÜSTUNGEN FÜR DIE Extrusionstechnik and Institut DU Cerveau ET DE LA Moelle Epiniere.

Inoex Innovatione…

7
Inoptec Zweignied…

7
Inoso

7
Inria Institut Na…

7
Inside Biometrics…

7
Inspectron

7
Institut CatalÀ D…

7
Institut DU Cerve…

7
Inserm-institut D… ◀

7

What this shows Inserm-institut holds 7 patents at rank #35,832, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inserm-institut

By rank, the assignees closest to #35,832 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Inserm-institut's primary technology class.

Inserm-institut's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Inserm-institut DE LA Recherche MÉDICALE patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	4	57.1%
2019	3	42.9%

Which technologies does Inserm-institut DE LA Recherche MÉDICALE patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

A61B - DIAGNOSIS; SURGERY; Identification 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Inserm-institut DE LA Recherche MÉDICALE's patent record in context - here's where to go next.

Inserm-institut DE LA Recherche MÉDICALE's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 85.7% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #35,891 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inserm-institut DE LA Recherche MÉDICALE against Inoex GMBH Innovationen UND AUSRÜSTUNGEN FÜR DIE Extrusionstechnik, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.